What Has Been the Growth of the Advanced Therapeutics Pharmaceutical Outsourcing Market So Far?
The advanced therapeutics pharmaceutical outsourcing market has seen considerable growth due to a variety of factors.
• The market size of advanced therapeutics pharmaceutical outsourcing has experienced consistent growth in recent times. It is projected to increase from $8.07 billion in 2024 to $8.43 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%.
Factors such as the development of biopharmaceutical infrastructure, regulatory compliance, rising demand for innovative drugs to address chronic and fatal diseases, enhanced efficiency, and an increasing desire for personalized medicine accounted for the growth during the historic period.
How Will the Advanced Therapeutics Pharmaceutical Outsourcing Market Size In The Coming Years?
The advanced therapeutics pharmaceutical outsourcing market is expected to maintain its strong growth trajectory in upcoming years.
• Forecasted to experience robust expansion in the upcoming years, the advanced therapeutics pharmaceutical outsourcing market is set to reach $10.27 billion by 2029, with a compound annual growth rate (CAGR) of 5.1%.
This predicted growth during the anticipation period can be attributed to factors such as the growing adoption of cell and gene therapies, a heightened focus on mRNA therapies, escalating demand for state-of-the-art treatments, and the effective and cost-saving solutions offered by outsourcing partners, coupled with collaborative innovation. The forecast period is also expected to witness key trends like technological advancements, the rise of expertise in advanced therapeutics, burgeoning pipelines of innovative therapies, incorporation of state-of-the-art technology, and rapid progress in gene therapy, cell therapy, and mRNA technologies.
What Main Forces Are Fueling Expansion In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
The advanced therapeutics pharmaceutical outsourcing market is anticipated to witness significant growth due to the growing utilization of cell and gene therapies. These novel therapies employ living cells or genetic material to treat or potentially cure diseases. Advanced therapeutics pharmaceutical outsourcing provides valuable access to providers with established reputations and skilled personnel, reducing the need for companies to devote time and resources to team-building. For instance, as per a November 2023 report by Nature, a scientific journal based in the UK, the quantity of new patients undergoing gene therapy treatments is predicted to escalate from 16,244 in 2020 to 94,696 in 2025. Consequently, the rising implementation of cell and gene therapies is propelling the expansion of the advanced therapeutics pharmaceutical outsourcing market.
What Key Areas Define The Segmentation Of The Global Advanced Therapeutics Pharmaceutical Outsourcing Market?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
Pre-Book The Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Advanced Therapeutics Pharmaceutical Outsourcing Market?
In the advanced therapeutics pharmaceutical outsourcing market, leading firms are prioritizing strategic collaborations to deliver dependable services to their clients. A strategic collaboration refers to a joint agreement between two or more parties (usually businesses) to accomplish mutual objectives that could not be achieved individually. For example, in January 2023, Lonza, a Swiss manufacturer for the pharmaceutical, biotechnology, and nutrition industries, formed a partnership with Context Therapeutics Inc., an American biopharmaceutical company that is pioneering medicines for solid tumors. The collaboration entails Lonza offering manufacturability evaluations, gene and cell line creation, and procedural development for both the drug substance and drug product.
Who Are the Key Players In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market report are:
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• IQVIA
• ICON plc
• SGS SA
• Lonza Group
• Parexel International Corporation
• WuXi AppTec
• Syneos Health
• Catalent Inc.
• Charles River Laboratories International
• Recipharm AB
• Croda International Plc
• Samsung Biologics
• Vetter Pharma International GmbH
• Medpace Holdings Inc.
• Fujifilm Diosynth Biotechnologies
• Marken
• AGC Biologics
• Evotec SE
• ProPharma Group
• Piramal Pharma Solutions
• Corden Pharma International LLC
• Novotech Pty Ltd.
• Cryoport Systems Inc.
• Cytovance Biologics
What Is The Most Dominant Region In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2024. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
